NCT04711200
- Conditions
- Adipose Derived Stromal Cells, Chemically-Induced Disorders, Dermatitis, +20 more
- Locations
-
- Henri Mondor Créteil, France
Clinical trial condition
Toxic Epidermal Necrolysis
Explore clinical trials studying Toxic Epidermal Necrolysis. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Toxic Epidermal Necrolysis trial results
NCT06119490
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
- Locations
-
- Department of Dermatology, the First Affiliated Hospital of Fujian Medical University. Fuzhou, Fujian, China
Not Yet Recruiting
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.
NCT07110662
- Conditions
- Chemically-Induced Disorders, Cutaneous Adverse Drug Reactions (CADR), Dermatitis, +17 more
- Locations
-
- Reference Center for Toxic, Toxin and Toxidermal Bullous Dermatoses - E. Herriot Hospital Lyon, France
NCT06474078
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
NCT01696500
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
- Locations
-
- Nihon Pharmaceutical Co., Ltd Tokyo, Japan